Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases.
Seventy patients with malignant lymphomas, including the entity known as polymorphic reticulosis (PR), involving the nose, nasal sinuses, nasopharynx, oropharynx (excluding tonsil), and larynx were studied. There were 26 cases of PR, 19 cases of lymphoma with features of PR (ML[PR]) and 25 cases of conventional lymphomas. Fourteen of the 25 conventional lymphomas were due to dissemination from distant sites. For all histologic types of primary lymphoma, the presenting symptoms were similar, and the nasal cavity was more commonly involved than the nasopharynx. Patients with PR were younger, had a higher male:female ratio, and had a better overall survival rate than patients with conventional lymphomas. Cryostat section immunohistochemistry performed on 17 samples from 16 patients showed only one B lymphoma out of 11 primary lesions; the other 10 cases and three recurrent tumors at distant sites showed phenotypic markers of T lymphocytes and natural killer cells. All three secondary tumors were of B-cell type. Of eight patients with sequential biopsies, progression to a more malignant histopathologic type was found in six. In the PR and ML[PR] biopsies, angiocentricity was detected in 11%, and angioinvasion in 22%. We could not confirm identity of PR with other angiocentric immunoproliferative lesions.
Ho
F C
FC
Department of Pathology, University of Hong Kong.
Choy
D
D
Loke
S L
SL
Kung
I T
IT
Fu
K H
KH
Liang
R
R
Todd
D
D
Khoo
R K
RK
D006801:Humans; D016130:Immunophenotyping; D007160:Immunoproliferative Disorders / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D008206:Lymphatic Diseases / Q000473:pathology*; D008223:Lymphoma / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D009669:Nose Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D009959:Oropharyngeal Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D011379:Prognosis